Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - New York Stock Exchange, Inc. - US7616241052 - Common Stock - Currency: USD

39.98  +0.01 (+0.03%)

Fundamental Rating

6

Overall REX gets a fundamental rating of 6 out of 10. We evaluated REX against 212 industry peers in the Oil, Gas & Consumable Fuels industry. REX has an excellent financial health rating, but there are some minor concerns on its profitability. REX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year REX was profitable.
In the past year REX had a positive cash flow from operations.
In the past 5 years REX has always been profitable.
In the past 5 years REX always reported a positive cash flow from operatings.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

REX has a Return On Assets of 8.08%. This is in the better half of the industry: REX outperforms 75.94% of its industry peers.
REX has a Return On Equity of 10.38%. This is comparable to the rest of the industry: REX outperforms 55.19% of its industry peers.
REX has a Return On Invested Capital (7.40%) which is comparable to the rest of the industry.
REX had an Average Return On Invested Capital over the past 3 years of 6.75%. This is significantly below the industry average of 27.43%.
The last Return On Invested Capital (7.40%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.08%
ROE 10.38%
ROIC 7.4%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

With a Profit Margin value of 9.05%, REX perfoms like the industry average, outperforming 51.89% of the companies in the same industry.
In the last couple of years the Profit Margin of REX has grown nicely.
REX has a Operating Margin of 10.01%. This is in the lower half of the industry: REX underperforms 63.21% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
The Gross Margin of REX (14.24%) is worse than 68.87% of its industry peers.
REX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.01%
PM (TTM) 9.05%
GM 14.24%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), REX is destroying value.
Compared to 1 year ago, REX has less shares outstanding
REX has less shares outstanding than it did 5 years ago.
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

An Altman-Z score of 5.86 indicates that REX is not in any danger for bankruptcy at the moment.
The Altman-Z score of REX (5.86) is better than 92.92% of its industry peers.
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.86
ROIC/WACC0.71
WACC10.45%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 8.64 indicates that REX has no problem at all paying its short term obligations.
The Current ratio of REX (8.64) is better than 95.28% of its industry peers.
REX has a Quick Ratio of 8.01. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.01, REX belongs to the top of the industry, outperforming 95.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.64
Quick Ratio 8.01
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

REX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 54.06% yearly.
Looking at the last year, REX shows a very negative growth in Revenue. The Revenue has decreased by -22.91% in the last year.
REX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-45.69%
Revenue 1Y (TTM)-22.91%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-15.66%

3.2 Future

REX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.03% yearly.
The Revenue is expected to grow by 10.00% on average over the next years. This is quite good.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.15, REX is valued correctly.
REX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of REX to the average of the S&P500 Index (28.29), we can say REX is valued rather cheaply.
With a Price/Forward Earnings ratio of 25.54, REX can be considered very expensive at the moment.
REX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. REX is more expensive than 60.85% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, REX is valued at the same level.
Industry RankSector Rank
PE 12.15
Fwd PE 25.54
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

96.23% of the companies in the same industry are more expensive than REX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.84
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

REX has a very decent profitability rating, which may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.22
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (4/21/2025, 2:29:17 PM)

39.98

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-26 2025-03-26/bmo
Earnings (Next)05-20 2025-05-20/bmo
Inst Owners85.03%
Inst Owner Change0.19%
Ins Owners13.72%
Ins Owner Change7.05%
Market Cap680.06M
Analysts80
Price Target58.4 (46.07%)
Short Float %2.73%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.27%
Min EPS beat(2)89.77%
Max EPS beat(2)122.77%
EPS beat(4)3
Avg EPS beat(4)63.66%
Min EPS beat(4)-1.27%
Max EPS beat(4)122.77%
EPS beat(8)6
Avg EPS beat(8)83.77%
EPS beat(12)10
Avg EPS beat(12)106.16%
EPS beat(16)13
Avg EPS beat(16)892.42%
Revenue beat(2)2
Avg Revenue beat(2)6.3%
Min Revenue beat(2)3.38%
Max Revenue beat(2)9.23%
Revenue beat(4)2
Avg Revenue beat(4)1.92%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)9.23%
Revenue beat(8)5
Avg Revenue beat(8)4.27%
Revenue beat(12)8
Avg Revenue beat(12)3%
Revenue beat(16)11
Avg Revenue beat(16)3.53%
PT rev (1m)-4.18%
PT rev (3m)-4.18%
EPS NQ rev (1m)30.77%
EPS NQ rev (3m)27.34%
EPS NY rev (1m)14.81%
EPS NY rev (3m)-31.42%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)8.87%
Revenue NY rev (1m)-5.04%
Revenue NY rev (3m)-6.29%
Valuation
Industry RankSector Rank
PE 12.15
Fwd PE 25.54
P/S 1.06
P/FCF N/A
P/OCF 10.59
P/B 1.21
P/tB 1.21
EV/EBITDA 1.84
EPS(TTM)3.29
EY8.23%
EPS(NY)1.57
Fwd EY3.92%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)3.77
OCFY9.44%
SpS37.77
BVpS32.94
TBVpS32.94
PEG (NY)N/A
PEG (5Y)0.22
Profitability
Industry RankSector Rank
ROA 8.08%
ROE 10.38%
ROCE 9.61%
ROIC 7.4%
ROICexc 15.96%
ROICexgc 15.96%
OM 10.01%
PM (TTM) 9.05%
GM 14.24%
FCFM N/A
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 328.43%
Cap/Sales 11.1%
Interest Coverage 250
Cash Conversion 74.6%
Profit Quality N/A
Current Ratio 8.64
Quick Ratio 8.01
Altman-Z 5.86
F-Score7
WACC10.45%
ROIC/WACC0.71
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-45.69%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.91%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-15.66%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.55%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.84%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%